Diabetes mellitus. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: The intervention group will be adherence to DASH diet for a period of 12 weeks. Intervention 2: The control group will be adherence to American Diabetes Association recommendations f
Prevention
The intervention group will be adherence to DASH diet for a period of 12 weeks.
The control group will be adherence to American Diabetes Association recommendations for a period of 12 weeks.
Sponsors
Urmia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Criteria for inclusion in the study: Suffering from diabetes type 2; Not Suffering from any diabetic complications such as nephropathy, retinopathy, neuropathy and cardiovascular complications; Aged between 18 to 65; Consumption of same drugs (glibenclamide, metformin). Criteria for exclusion from the study: Suffering from diabetes type 1; Insulin Therapy; Suffering from liver diseases; Suffering from renal diseases; Suffering from thyroid disease; Pregnancy and lactation; Smoking and drinking alcohol; Consumption of drugs reducing blood fat and pressure and Weight, thiazide diuretics and corticosteroids; Change of type and dosage of consuming drugs during the study; Consumption of Herbal or chemical supplements; Suffering from Electrolyte abnormalities and Digestive diseases associated with malabsorption; Gastric bypass surgery and cholecystectomy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total cholesterol. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: enzymatic method, mg/dl.;Triglyceride. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: enzymatic method, mg/dl.;HDL cholesterol. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: enzymatic method, mg/dl.;LDL cholesterol. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: enzymatic method, mg/dl.;VLDL cholesterol. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: Triglyceride/5, if TG>400: VLDL-C = TC – (HDL-C + LDL-C), mg/dl.;Free Fatty Acid. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: ELISA method, nmol/ml.;Weight. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: Inbody770 Body Analyzer, kg. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: Mercury sphygmomanometer, mmHg.;Diastolic blood pressure. Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: Mercury sphygmomanometer, mmHg.;Body composition analysis (Fat mass, Fat free mass, Body water, Body cell mass, Skeletal muscle mass). Timepoint: Before Intervention and 12 weeks after Intervention. Method of measurement: Inbody770 Body Analyzer, Bioelectrical impedance analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Manafi
Urmia University of Medical Sciences
Outcome results
None listed